The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Microparticles and nanoparticles for drug delivery
Open accessAbstract
Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between micro‐ and nanoparticles, being particles with dimensions best described in micrometers and nanometers respectively. That size difference entails real differences at many levels, from formulation to in vivo usage. Here I will discuss those differences and provide examples of applications, for local and systemic drug delivery. I will outline a number of challenges of interest in particulate drug delivery. Biotechnol. Bioeng. 2007;96: 203–209. © 2006 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Pegylation: A Novel Process for Modifying Pharmacokinetics
Harris, J. M., Martin, N. E., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913
Polymers for gene delivery across length scales
Putnam, D. (2006) · Nature Materials · doi:10.1038/nmat1645 · Cited by 572
Trojan particles: Large porous carriers of nanoparticles for drug delivery
Tsapis, N., Bennett, D., Jackson, B., Weitz, D. A., & Edwards, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182233999 · Cited by 546
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Tabata, Y., & Ikada, Y. (1988) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820221002 · Cited by 235
Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines
Little, S. R., Lynn, D. M., Ge, Q., Anderson, D. G., Puram, S. V., Chen, J., Eisen, H. N., & Langer, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403549101 · Cited by 227
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
Kohane, D. S., Tse, J. Y., Yeo, Y., Padera, R., Shubina, M., & Langer, R. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30654 · Cited by 217
Self-citationSpragg, D. D., Alford, D. R., Greferath, R., Larsen, C. E., Lee, K.-D., Gurtner, G. C., Cybulsky, M. I., Tosi, P. F., Nicolau, C., & Gimbrone, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8795 · Cited by 212
Complex Coacervates for Thermally Sensitive Controlled Release of Flavor Compounds
Yeo, Y., Bellas, E., Firestone, W., Langer, R., & Kohane, D. S. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0507947 · Cited by 208
Self-citationBiodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres
Menei, P., Daniel, V, Montero-Menei, C., Brouillard, M., Pouplard-Barthelaix, A., & Benoit, J. P. (1993) · Biomaterials · doi:10.1016/0142-9612(93)90151-q · Cited by 180
Glucocorticoids Prolong Rat Sciatic Nerve Blockade In Vivo from Bupivacaine Microspheres
Castillo, J., Curley, J., Hotz, J., Uezono, M., Tigner, J., Chasin, M., Wilder, R., Langer, R., & Berde, C. (1996) · Anesthesiology · doi:10.1097/00000542-199611000-00025 · Cited by 175
Watts, P. J., Davies, M. C., & Melia, C. D. (1990) · PubMed · Cited by 148
Tuftsin-bearing liposomes in treatment of macrophage-based infections
Agrawal, A. K., & Gupta, C. M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00061-7 · Cited by 135
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres
Kohane, D. S., Smith, S. E., Louis, D. N., Colombo, G., Ghoroghchian, P. P., Hunfeld, N., Berde, C. B., & Langer, R. (2003) · Pain · doi:10.1016/s0304-3959(03)00049-6 · Cited by 120
Self-citationReddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M. J., & Rouse, B. T. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90142-3 · Cited by 112
Yeo, Y., Ito, T., Bellas, E., Highley, C. B., Marini, R. P., & Kohane, D. S. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251519.49405.55 · Cited by 105
Self-citationJebria, A. B., Chen, D., Eskew, M. L., Rita Vanbever, A., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018879331061 · Cited by 104
Biocompatibility of lipid‐protein‐sugar particles containing bupivacaine in the epineurium
Kohane, D. S., Lipp, M. M., Kinney, R. C., Anthony, D. C., Louis, D. N., Lotan, N., & Langer, R. (2001) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1261 · Cited by 102
Self-citationLongmuir, K. J., Robertson, R. T., Haynes, S. M., Baratta, J. L., & Waring, A. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9609-x · Cited by 80
Peritoneal application of chitosan and UV‐cross‐linkable chitosan
Yeo, Y., Burdick, J. A., Highley, C. B., Marini, R. P., Langer, R., & Kohane, D. S. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30740 · Cited by 70
Self-citationpH-Triggered Microparticles for Peptide Vaccination
Haining, W. N., Anderson, D. G., Little, S. R., von Berwelt-Baildon, M. S., Cardoso, A. A., Alves, P. M. S., Kosmatopoulos, K., Nadler, L. M., Langer, R., & Kohane, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2578 · Cited by 68
Self-citationColombo, G., Padera, R. F., Langer, R., & Kohane, D. S. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30443 · Cited by 61
Self-citationHöckel, M., Ott, S., Siemann, U., & Kissel, T. (1987) · PubMed · Cited by 43
Lipid–sugar particles for intracranial drug delivery: safety and biocompatibility
Kohane, D. S., Plesnila, N., Thomas, S. S., Le, D. A., Langer, R., & Moskowitz, M. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02878-0 · Cited by 39
Self-citation
Cited by
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Protein–polysaccharide complexes and coacervates
Turgeon, S. L., Schmitt, C., & Sanchez, C. (2007) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2007.07.007 · Cited by 649
Remotely Triggerable Drug Delivery Systems
Timko, B. P., Dvir, T., & Kohane, D. S. (2010) · Advanced Materials · doi:10.1002/adma.201002072 · Cited by 614
Self-citationMerkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Metadata
- Authors
- Kohane, D. S.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2006-12-26
- Volume
- 96
- Issue
- 2
- Pages
- 203-209
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2050555768
- Cited by
- 517
- References
- 27
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
